Oakhill Veterinary Centre Limited 08379696 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true true false 08379696 2023-03-01 2024-02-29 08379696 2024-02-29 08379696 bus:OrdinaryShareClass1 2024-02-29 08379696 core:RetainedEarningsAccumulatedLosses 2024-02-29 08379696 core:ShareCapital 2024-02-29 08379696 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2024-02-29 08379696 core:CurrentFinancialInstruments 2024-02-29 08379696 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 08379696 core:CurrentFinancialInstruments core:WithinOneYear 2 2024-02-29 08379696 core:Non-currentFinancialInstruments 2024-02-29 08379696 core:Non-currentFinancialInstruments core:AfterOneYear 2024-02-29 08379696 core:Goodwill 2024-02-29 08379696 core:FurnitureFittingsToolsEquipment 2024-02-29 08379696 core:LandBuildings 2024-02-29 08379696 core:MotorVehicles 2024-02-29 08379696 core:DeferredTaxation 2024-02-29 08379696 1 2024-02-29 08379696 bus:FRS102 2023-03-01 2024-02-29 08379696 bus:Audited 2023-03-01 2024-02-29 08379696 bus:FullAccounts 2023-03-01 2024-02-29 08379696 bus:RegisteredOffice 2023-03-01 2024-02-29 08379696 bus:Director1 2023-03-01 2024-02-29 08379696 bus:Director1 1 2023-03-01 2024-02-29 08379696 bus:Director3 2023-03-01 2024-02-29 08379696 bus:Director4 2023-03-01 2024-02-29 08379696 bus:Director5 2023-03-01 2024-02-29 08379696 bus:Director6 2023-03-01 2024-02-29 08379696 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 08379696 bus:Consolidated 2023-03-01 2024-02-29 08379696 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 08379696 core:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 08379696 core:ShareCapital 2023-03-01 2024-02-29 08379696 core:Goodwill 2023-03-01 2024-02-29 08379696 core:PlantEquipmentUnderOperatingLeases 2023-03-01 2024-02-29 08379696 core:FurnitureFittings 2023-03-01 2024-02-29 08379696 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 08379696 core:LandBuildings 2023-03-01 2024-02-29 08379696 core:MotorCars 2023-03-01 2024-02-29 08379696 core:MotorVehicles 2023-03-01 2024-02-29 08379696 core:DeferredTaxation 2023-03-01 2024-02-29 08379696 core:UKTax 2023-03-01 2024-02-29 08379696 1 2023-03-01 2024-02-29 08379696 1 2023-03-01 2024-02-29 08379696 countries:AllCountries 2023-03-01 2024-02-29 08379696 2023-02-28 08379696 core:RetainedEarningsAccumulatedLosses 2023-02-28 08379696 core:ShareCapital 2023-02-28 08379696 core:Goodwill 2023-02-28 08379696 core:FurnitureFittingsToolsEquipment 2023-02-28 08379696 core:LandBuildings 2023-02-28 08379696 core:MotorVehicles 2023-02-28 08379696 core:DeferredTaxation 2023-02-28 08379696 2022-03-01 2023-02-28 08379696 2023-02-28 08379696 bus:OrdinaryShareClass1 2023-02-28 08379696 core:RetainedEarningsAccumulatedLosses 2023-02-28 08379696 core:ShareCapital 2023-02-28 08379696 core:CurrentFinancialInstruments 2023-02-28 08379696 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 08379696 core:CurrentFinancialInstruments core:WithinOneYear 2 2023-02-28 08379696 core:Non-currentFinancialInstruments 2023-02-28 08379696 core:Non-currentFinancialInstruments core:AfterOneYear 2023-02-28 08379696 core:Goodwill 2023-02-28 08379696 core:FurnitureFittingsToolsEquipment 2023-02-28 08379696 core:LandBuildings 2023-02-28 08379696 core:MotorVehicles 2023-02-28 08379696 1 2023-02-28 08379696 core:RetainedEarningsAccumulatedLosses 2022-03-01 2023-02-28 08379696 core:ShareCapital 2022-03-01 2023-02-28 08379696 core:PlantEquipmentUnderOperatingLeases 2022-03-01 2023-02-28 08379696 core:UKTax 2022-03-01 2023-02-28 08379696 2022-02-28 08379696 core:RetainedEarningsAccumulatedLosses 2022-02-28 08379696 core:ShareCapital 2022-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08379696

Oakhill Veterinary Centre Limited

Annual Report and Audited Financial Statements

for the Year Ended 29 February 2024

 

Oakhill Veterinary Centre Limited

Contents

Company Information

1

Strategic Report

2 to 3

Directors' Report

4 to 5

Statement of Directors' Responsibilities

6

Independent Auditor's Report

7 to 10

Profit and Loss Account

11

Statement of Comprehensive Income

12

Balance Sheet

13

Statement of Changes in Equity

14

Statement of Cash Flows

15

Notes to the Financial Statements

16 to 25

 

Oakhill Veterinary Centre Limited

Company Information

Directors

Mr P Acton

Mrs JA Lee

Ms T Towers

Mr M Murphy

Mr G J Hinnigan

Registered office

Langley Lane
Goosnargh
Preston
Lancashire
PR3 2JQ

Auditors

Moore Scarrott Audit Limited
Registered Auditors
Calyx House
South Road
Taunton
Somerset
TA1 3DU

 

Oakhill Veterinary Centre Limited

Strategic Report for the Year Ended 29 February 2024

The directors present their strategic report for the year ended 29 February 2024.

Principal activity

The principal activity of the company is the provision of veterinary services.

Fair review of the business

The year ended 29 February 2024 has been another year of growth as shown by the increase in turnover and gross profit achieved in the year.

The continued growth has been achieved by investing in both our staff and our facilities to ensure a high level of customer service from our talented and experienced team.

The continued aim of the business is to grow further and maintain high service levels.

The company's key financial and other performance indicators during the year were as follows:

Financial KPIs

Unit

2024

2023

Gross Profit Margin

%

73

74

Employment costs: Turnover

%

43

40

Staff costs: FTE

109

104

Principal risks and uncertainties

Competition in the industry has become more intense, and there is a constant need to keep up to date in terms of equipment, branch appearances and digital capabilities. To counter this, the business has continued its investment in equipment, refurbishments and the development of its staff.

The needs of the more demanding customers are constantly being evaluated and opportunities created. The company is committed to improve engagement with its clients by providing more services, better facilities and to improve communication.

The wider economic environment continues to be challenged due to the impacts of Brexit and Covid-19. The business is satisfied that it's resources and level of borrowing is adequate to counter any possible adverse effects. The veterinary industry has been relatively insulated from economic turbulence in the past due in part to the increase in the use of pet insurance and activities not necessarily related to footfall such as pet health plans.

 

Oakhill Veterinary Centre Limited

Strategic Report for the Year Ended 29 February 2024

Section 172(1) statement

The Directors understand the business, strategic targets and ever-changing market and environment that the company operates in. Strategic decisions are taken at board level, where the Directors take decisions they believe are in the best interests of the company, members and stakeholders. The board meets every month to discuss current topics across all areas of the business. They receive an overview of the current financial performance and discuss matters of importance during the board meetings.

The Directors recognise that the employees are fundamental and are integral to the business to deliver strategic ambitions. The success of the business depends on attracting, retaining, and motivating employees. Directors ensure that the company does the upmost to be a responsible employer considering pay, benefits, upkeep of health and safety requirements, and workplace environments. When making decisions, the Directors factor the implication of decisions on the employees where it is relevant and possible to do so.

The Directors recognise that in order to achieve its strategic objectives, it must have strong relationships with its customers and suppliers. The Directors receive regular information and feedback from business operations that inform them how current and emerging relationships are developing. The Directors actively seek and receive third party information indicating performance from a customer point of view. The Directors also receive regular updates on supplier activities and contract management topics.

The Directors will take into account the impact of the company's operations on the community and environment in any decision-making process where it is necessary to do. The Directors are fully aware of their legal responsibilities and obligations, including company policies which are designed to uphold the core values of Oakhill Veterinary Centre, and ensure all stakeholders conduct themselves as it would expect. By following these principles and guidelines, the business is conducted with the upmost integrity. Regular internal reviews take place, which help ensure that the guidelines are followed and identify any areas or processes that can be improved.

The Directors consider the best possible action in its decision-making process to deliver their strategy. When making these decisions the Directors act as fairly as they can for all members however this can mean that sometimes certain stakeholder interests may not be fully aligned.

The Board understand their duties and responsibilities individually and collectively. They have acted in accordance with their duties codified in law, which include their duty to act in a way in which they consider would be most likely to promote the success of the company to the benefit of its members whilst considering the stakeholders of the company and matters set out in section 172 (1) of the Companies Act 2006.

Approved by the Board on 28 November 2024 and signed on its behalf by:

Mr P Acton
Director

   
     
 

Oakhill Veterinary Centre Limited

Directors' Report for the Year Ended 29 February 2024

The directors present their report and the financial statements for the year ended 29 February 2024.

Directors of the company

The directors who held office during the year were as follows:

Mr P Acton

Mrs JA Lee

Ms T Towers

Mr M Murphy

Mr G J Hinnigan

Dividends

The Directors recommend a final dividend payment of £351,120 be made in respect of the financial year ended 29 February 2024 (2023: £420,903). This dividend has not been recognised as a liability in the financial statements.
 

Financial instruments

Objectives and policies

The company's principal financial assets are its bank balances, fixed assets and debtors. The company's credit risk is primarily attributable to its trade debtors. To mitigate this credit risk, the business uses a combination of internal credit control functions and external debt collection agencies. The accounts presented in the balance sheet are net of provisions for doubtful debts. The company does not purchase any significant goods or services in foreign currencies.

Price risk, credit risk, liquidity risk and cash flow risk

The company is exposed to fair value interest rate risk on its fixed rate borrowings and cash flow interest risk on any floating rate borrowings. In order to maintain liquidity and ensure that sufficient funds are available for ongoing operations and future developments, the company uses a mixture of long-term and short-term debt finance.

Research and development

The Directors are committed to fostering innovation and ensuring the company remains at the forefront of its industry through ongoing research and development (R&D) activities. During the year 29 February 2024 the company undertook several significant R&D projects aimed at enhancing and revolutionising small animal, farm animal, and equine medical treatments. The Directors believe that these investments are crucial for maintaining the company’s competitive edge and driving future growth. We are confident that our continued focus on R&D will result in significant benefits, including the enhancement of our market position as well as improved medical care for our patients.

Future developments

The Directors expect the business to continue operating along similar lines to the current year for the next financial year. The Directors remain focused on maintaining operational efficiency and financial stability while carefully monitoring external factors that may affect future performance.

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

 

Oakhill Veterinary Centre Limited

Directors' Report for the Year Ended 29 February 2024

Approved by the Board on 28 November 2024 and signed on its behalf by:

Mr P Acton
Director

   
     
 

Oakhill Veterinary Centre Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Oakhill Veterinary Centre Limited

Independent Auditor's Report to the Members of Oakhill Veterinary Centre Limited

Opinion

We have audited the financial statements of Oakhill Veterinary Centre Limited (the 'company') for the year ended 29 February 2024, which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 29 February 2024 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Oakhill Veterinary Centre Limited

Independent Auditor's Report to the Members of Oakhill Veterinary Centre Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities [set out on page 6], the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Oakhill Veterinary Centre Limited

Independent Auditor's Report to the Members of Oakhill Veterinary Centre Limited

We considered the nature of the company's industry and its control environment, and reviewed the company's documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.

We obtained an understanding of the legal and regulatory frameworks that the company operates in, and identified the key laws and regulation that:

had a direct effect on the determination of material amounts and disclosures in the financial statements. These included UK Companies Act, pensions legislation, tax legislation; and

do not have a direct effect on the financial statements but compliance with which may be fundamental to the company's ability to operate or to avoid a material penalty. These included the company's compliance with the RCVS regulations applicable to all practices and qualified nurses, GDPR, Veterinary Surgeons Act 1966, Animal Welfare Act 2006, Veterinary Medicines Regulations 2013 and The Animal Act 1986.

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

In addition to the above, our procedures to respond to the risks identified included the following:

- reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

- performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

- enquiring of management and external legal counsel concerning actual and potential litigation and claims, and instances of non-compliance with laws and regulations; and

- reading minutes of meetings of those charged with governance

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

 

Oakhill Veterinary Centre Limited

Independent Auditor's Report to the Members of Oakhill Veterinary Centre Limited





Duncan Nicholas FCA (Senior Statutory Auditor)
For and on behalf of Moore Scarrott Audit Limited, Statutory Auditor

Calyx House
South Road
Taunton
Somerset
TA1 3DU

28 November 2024

 

Oakhill Veterinary Centre Limited

Profit and Loss Account for the Year Ended 29 February 2024

Note

2024
£

2023
£

Turnover

3

9,574,398

8,627,975

Cost of sales

 

(2,610,432)

(2,212,436)

Gross profit

 

6,963,966

6,415,539

Administrative expenses

 

(5,798,520)

(4,884,896)

Other operating income

4

1,200

20,623

Operating profit

5

1,166,646

1,551,266

Other interest receivable and similar income

6

1,853

834

Interest payable and similar expenses

7

(29,018)

(84,924)

   

(27,165)

(84,090)

Profit before tax

 

1,139,481

1,467,176

Tax on profit

9

183,079

(333,702)

Profit for the financial year

 

1,322,560

1,133,474

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

 

Oakhill Veterinary Centre Limited

Statement of Comprehensive Income for the Year Ended 29 February 2024

2024
£

2023
£

Profit for the year

1,322,560

1,133,474

Total comprehensive income for the year

1,322,560

1,133,474

 

Oakhill Veterinary Centre Limited

(Registration number: 08379696)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

10

851,500

917,000

Tangible assets

11

1,671,022

1,786,285

Other financial assets

12

10,000

10,000

 

2,532,522

2,713,285

Current assets

 

Stocks

13

273,889

241,194

Debtors

14

2,555,749

2,263,918

Cash at bank and in hand

 

769,069

514,044

 

3,598,707

3,019,156

Creditors: Amounts falling due within one year

16

(1,571,889)

(2,094,435)

Net current assets

 

2,026,818

924,721

Total assets less current liabilities

 

4,559,340

3,638,006

Creditors: Amounts falling due after more than one year

16

(79,546)

(143,182)

Provisions for liabilities

17

(236,050)

(222,520)

Net assets

 

4,243,744

3,272,304

Capital and reserves

 

Called up share capital

250

250

Retained earnings

4,243,494

3,272,054

Shareholders' funds

 

4,243,744

3,272,304

Approved and authorised by the Board on 28 November 2024 and signed on its behalf by:
 

Mr P Acton
Director

   
     
 

Oakhill Veterinary Centre Limited

Statement of Changes in Equity for the Year Ended 29 February 2024

Share capital
£

Retained earnings
£

Total
£

At 1 March 2023

250

3,272,054

3,272,304

Profit for the year

-

1,322,560

1,322,560

Dividends

-

(351,120)

(351,120)

At 29 February 2024

250

4,243,494

4,243,744

Share capital
£

Retained earnings
£

Total
£

At 1 March 2022

250

2,559,483

2,559,733

Profit for the year

-

1,133,474

1,133,474

Dividends

-

(420,903)

(420,903)

At 28 February 2023

250

3,272,054

3,272,304

 

Oakhill Veterinary Centre Limited

Statement of Cash Flows for the Year Ended 29 February 2024

Note

2024
£

2023
£

Cash flows from operating activities

Profit for the year

 

1,322,560

1,133,474

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

5

362,810

313,100

Loss/(profit) on disposal of tangible assets

14,213

(1,350)

Finance income

6

(1,853)

(834)

Finance costs

7

29,018

84,924

Income tax expense

9

(183,079)

333,702

 

1,543,669

1,863,016

Working capital adjustments

 

Increase in stocks

13

(32,695)

(48,595)

Increase in debtors

14

(95,157)

(62,755)

Decrease in creditors

16

(315,185)

(544,635)

Cash generated from operations

 

1,100,632

1,207,031

Income taxes paid

9

(207,426)

(247,327)

Net cash flow from operating activities

 

893,206

959,704

Cash flows from investing activities

 

Interest received

6

1,853

834

Acquisitions of tangible assets

(218,717)

(1,041,709)

Proceeds from sale of tangible assets

 

22,455

25,500

Net cash flows from investing activities

 

(194,409)

(1,015,375)

Cash flows from financing activities

 

Interest paid

7

(29,018)

(84,924)

Repayment of bank borrowing

 

(63,634)

(63,637)

Payments to finance lease creditors

 

-

(13,494)

Dividends paid

(351,120)

(420,903)

Net cash flows from financing activities

 

(443,772)

(582,958)

Net increase/(decrease) in cash and cash equivalents

 

255,025

(638,629)

Cash and cash equivalents at 1 March

 

514,044

1,152,673

Cash and cash equivalents at 29 February

 

769,069

514,044

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales (registered number 08379696).

The address of its registered office is:
Langley Lane
Goosnargh
Preston
Lancashire
PR3 2JQ

These financial statements were authorised for issue by the Board on 28 November 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold improvements

15% reducing balance

Fixtures & fittings

15% reducing balance

Motor vehicles

25% reducing balance

Goodwill

Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

5% straight line

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in the profit or loss account. Investments in equity shares where fair value cannot be measured reliably are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Turnover

The analysis of the company's Turnover for the year from continuing operations is as follows:

2024
£

2023
£

Turnover

9,574,398

8,627,975

4

Other operating income

The analysis of the company's other operating income for the year is as follows:

2024
£

2023
£

Miscellaneous other operating income

1,200

20,623

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

5

Operating profit

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

297,310

247,600

Amortisation expense

65,500

65,500

Operating lease expense - plant and machinery

40,880

44,211

Loss/(profit) on disposal of property, plant and equipment

14,213

(1,350)

6

Other interest receivable and similar income

2024
£

2023
£

Interest income on bank deposits

450

361

Other finance income

1,403

473

1,853

834

7

Interest payable and similar expenses

2024
£

2023
£

Interest on bank overdrafts and borrowings

11,716

8,334

Interest on obligations under finance leases and hire purchase contracts

-

460

Interest expense on other finance liabilities

17,302

76,130

29,018

84,924

8

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2024
£

2023
£

Wages and salaries

4,034,380

3,421,699

Other employee expense

76,205

58,746

4,110,585

3,480,445

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2024
No.

2023
No.

Other departments

124

121

124

121

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

9

Taxation

Tax charged/(credited) in the profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax

124,852

207,426

UK corporation tax adjustment to prior periods

(321,461)

-

(196,609)

207,426

Deferred taxation

Arising from origination and reversal of timing differences

13,530

126,276

Tax (receipt)/expense in the income statement

(183,079)

333,702

The tax on profit before tax for the year is the same as the standard rate of corporation tax in the UK (2023- the same as the standard rate of corporation tax in the UK) of 25% (2023 - 19%).

The differences are reconciled below:

2024
£

2023
£

Profit before tax

1,139,481

1,467,176

Corporation tax at standard rate

284,870

278,763

Decrease in UK and foreign current tax from adjustment for prior periods

(321,461)

-

Tax increase/(decrease) from effect of capital allowances and depreciation

39,161

(70,821)

Decrease from effect of different UK tax rates on some earnings

(2,590)

-

Effect of expense not deductible in determining taxable profit (tax loss)

875

-

Tax decrease arising from group relief

(35,758)

-

Deferred tax expense relating to changes in tax rates or laws

-

124,984

Tax increase from changes in pension fund prepayment

372

296

Tax decrease from effect of adjustment in research and development tax credit

(162,054)

-

Tax increase in relation to deferred tax

13,530

-

Other tax effects for reconciliation between accounting profit and tax expense (income)

24

(480)

Total tax (credit)/charge

(183,079)

333,702

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

10

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 March 2023

1,310,000

1,310,000

At 29 February 2024

1,310,000

1,310,000

Amortisation

At 1 March 2023

393,000

393,000

Amortisation charge

65,500

65,500

At 29 February 2024

458,500

458,500

Carrying amount

At 29 February 2024

851,500

851,500

At 28 February 2023

917,000

917,000

11

Tangible assets

Land and buildings
£

Fixtures and fittings
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 March 2023

1,251,183

1,247,103

298,558

2,796,844

Additions

57,707

105,982

55,028

218,717

Disposals

(35,562)

(55,293)

(10,383)

(101,238)

At 29 February 2024

1,273,328

1,297,792

343,203

2,914,323

Depreciation

At 1 March 2023

359,350

468,302

182,909

1,010,561

Charge for the year

126,298

128,899

42,113

297,310

Eliminated on disposal

(22,819)

(33,594)

(8,157)

(64,570)

At 29 February 2024

462,829

563,607

216,865

1,243,301

Carrying amount

At 29 February 2024

810,499

734,185

126,338

1,671,022

At 28 February 2023

891,835

778,801

115,649

1,786,285

Included within the net book value of land and buildings above is £810,499 (2023 - £891,835) in respect of long leasehold land and buildings.
 

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

12

Other financial assets (current and non-current)

Financial assets at fair value through profit and loss
£

Total
£

Non-current financial assets

Cost or valuation

At 1 March 2023

10,000

10,000

At 29 February 2024

10,000

10,000

Impairment

Carrying amount

At 29 February 2024

10,000

10,000

13

Stocks

2024
£

2023
£

Stock

273,889

241,194

14

Debtors

Current

2024
£

2023
£

Trade debtors

747,543

644,429

Amounts owed by related parties

1,382,984

1,427,509

Other debtors

139,438

102,938

Prepayments

89,110

89,042

Corporation tax asset

196,674

-

 

2,555,749

2,263,918

15

Cash and cash equivalents

2024
£

2023
£

Cash on hand

504

395

Cash at bank

768,565

513,649

769,069

514,044

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

16

Creditors

Note

2024
£

2023
£

Due within one year

 

Bank loans and overdrafts

19

63,636

63,636

Trade creditors

 

685,427

481,655

Social security and other taxes

 

462,258

345,955

Outstanding defined contribution pension costs

 

21,668

17,898

Other payables

 

220,062

867,425

Accruals

 

118,838

110,505

Corporation tax

9

-

207,361

 

1,571,889

2,094,435

Due after one year

 

Bank loans and overdrafts

19

79,546

143,182

17

Provisions for liabilities

Deferred tax
£

Total
£

At 1 March 2023

222,520

222,520

Increase (decrease) in existing provisions

13,530

13,530

At 29 February 2024

236,050

236,050

18

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

250

250

250

250

       

19

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

79,546

143,182

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

Current loans and borrowings

2024
£

2023
£

Bank borrowings

63,636

63,636

Bank borrowings

The bank loan is denominated in £ with a nominal interest rate of nil%, and the final instalment is due on 31 May 2025. The carrying amount at year end is £143,182 (2023 - £206,818).

Security is given by way of a fixed and floating charge over all company assets.

20

Commitments

Other financial commitments

The total amount of other financial commitments not provided in the financial statements was £45,297 (2023 - £197,317).

 

Oakhill Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 29 February 2024

21

Related party transactions

Advances to directors


Mr P Acton

During the period Mr P Acton went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £914 (2023 - £Nil). At the year end the amount outstanding from Mr P Acton was £Nil (2023 - £Nil). Interest has been charged at the commercial rate.

Summary of transactions with other related parties


The company has taken advantage of the exemption available under Section 33 of FRS 102 Related Party Disclosures, and has not disclosed transactions or balances with related parties that are part of the group. This is on the grounds that it is a wholly-owned subsidary of Oakhill Management (Preston) Limited, which prepares consolidated financial statements that are publicly available and include the results of the company.

The consolidated financial statements of Oakhill Management (Preston) Limited can be accessed online at Companies House.

During the period Mr A Bramall went overdrawn on their shareholder's loan account. The maximum overdrawn balance during the year was £53,366 (2023 - £31,228). At the year end the amount outstanding from Mr A Bramall was £10,000 (2023 - £Nil). No interest was paid on this balance, and no security has been provided. All transactions with related parties are conducted at arm's length and on normal commercial terms.

During the period S Millward went overdrawn on their shareholder's loan account. The maximum overdrawn balance during the year was £63,248 (2023 - £39,209). At the year end the amount outstanding from Mr S Millward was £35,000 (2023 - £3,198). No interest was paid on this balance, and no security has been provided. All transactions with related parties are conducted at arm's length and on normal commercial terms

At the reporting date, the company had outstanding balances owed by entities that are Personal Investment Companies (PICs) owned by directors and/or shareholders of the company. In aggregate, the amount owed by Director-owned PICs was £72,247. A further £27,263 was owed by Shareholder-owned PICs. No interest was paid on these balances, and no security has been provided for them. All transactions with related parties are conducted at arm's length and on normal commercial terms.

22

Parent and ultimate parent undertaking

The company's immediate parent is Oakhill Holdings (Preston) Limited, incorporated in England and Wales.

 The ultimate parent is Oakhill Management (Preston) Limited, incorporated in England and Wales.

  These financial statements are available upon request from the company’s registered offices for the group accounts or are publicly available from Companies House.